Ignite Creation Date:
2025-12-25 @ 1:03 AM
Ignite Modification Date:
2025-12-25 @ 11:16 PM
Study NCT ID:
NCT04682093
Status:
UNKNOWN
Last Update Posted:
2020-12-24
First Post:
2020-12-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Risk Stratification of Patients With Suspected COVID-19 Presenting to the ED
Sponsor:
European Society for Emergency Medicine (EUSEM) Research Network
Organization:
Study Overview
Official Title:
Risk Stratification of Patients With Suspected COVID-19 Presenting to the ED (EUROCOV Study)
Status:
UNKNOWN
Status Verified Date:
2020-12
Last Known Status:
ENROLLING_BY_INVITATION
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EUROCOV
Brief Summary:
This project is an unfunded collaboration of approximately 30 emergency departments across Europe led by the EUSEM research network. It involves collection of data in relation to determining the epidemiology and outcome of adult patients who present to emergency departments with a suspected Covid infection.
Detailed Description:
Over the past 6 months, the world has faced a novel infection disease outbreak, due to a novel coronavirus, the severe acute respiratory syndrome coronavirus (SARS-CoV2), with a massive impact on healthcare resource.
In Europe, numbers of confirmed cases continue to rise. Europe is currently one of the regions with the highest number of Covid-19 cases and deaths due to this emergent diseases.
Most COVID-19 infected patients present with mild to moderate acute respiratory symptoms, including cough, fever, dyspnea and pneumonia. About 20% will present with severe or critical manifestations of the disease, including pneumonia, respiratory failure and acute respiratory distress syndrome (ARDS).
Anticipating the needs for hospitalization in ward and/or intensive care is crucial.
Emergency departments are at the front line for triaging patients with suspected Covid-19 and referring them to the appropriate level of care.
In Europe, the number of ED patients with suspected Covid-19 is variable; rate of hospitalization from ED reaches 40% for this population.
Risk stratification and management decisions of patients presenting to the ED with suspected COVID-19 is a challenge for emergency physicians.
In Europe, numbers of confirmed cases continue to rise. Europe is currently one of the regions with the highest number of Covid-19 cases and deaths due to this emergent diseases.
Most COVID-19 infected patients present with mild to moderate acute respiratory symptoms, including cough, fever, dyspnea and pneumonia. About 20% will present with severe or critical manifestations of the disease, including pneumonia, respiratory failure and acute respiratory distress syndrome (ARDS).
Anticipating the needs for hospitalization in ward and/or intensive care is crucial.
Emergency departments are at the front line for triaging patients with suspected Covid-19 and referring them to the appropriate level of care.
In Europe, the number of ED patients with suspected Covid-19 is variable; rate of hospitalization from ED reaches 40% for this population.
Risk stratification and management decisions of patients presenting to the ED with suspected COVID-19 is a challenge for emergency physicians.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: